UNVR · Univar Solutions Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Revenue | $11.48B | $9.54B | $8.27B | $9.29B | $8.07B | - |
| Cost of Revenue | - | - | - | - | $6.35B | - |
| Gross Profit | - | - | - | - | $1.73B | $1.81B |
| R&D | - | - | - | - | - | - |
| SG&A | $1.25B | $1.19B | $1.02B | $1.07B | $931.40M | $909.80M |
| Total Operating Expenses | $1.94B | $1.91B | $1.72B | $1.95B | $1.51B | $1.45B |
| D&A | $179.90M | $203.40M | $222.90M | $214.70M | $179.50M | $200.40M |
| Operating Income | $832.60M | $483.80M | $282.20M | $187.30M | $387.40M | $353.80M |
| Interest Expense | $107.20M | $101.50M | $114.50M | $147.20M | $135.60M | $152.00M |
| Income Tax | $210.90M | $124.60M | $6.10M | $104.50M | $49.90M | $49.00M |
| Net Income | $545.30M | $460.60M | $52.90M | ($100.20M) | $172.30M | $119.80M |
| EPS - Basic | $3.29 | $2.71 | $0.31 | ($0.61) | $1.22 | $0.85 |
| EPS - Diluted | $3.26 | $2.69 | $0.31 | ($0.61) | $1.21 | $0.85 |
Balance Sheet
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $385.30M | $251.50M | $386.60M | $336.40M | $121.60M | $467.00M |
| Accounts Receivable | $1.49B | $1.54B | $1.24B | $1.16B | $1.09B | $1.06B |
| Inventory | $1.14B | $932.20M | $674.00M | $796.00M | $803.30M | $839.50M |
| Accounts Payable | $982.50M | $1.01B | $765.10M | $895.00M | $925.40M | $941.70M |
| Current Assets | $3.23B | $2.89B | $2.45B | $2.45B | $2.19B | $2.52B |
| Total Assets | $7.15B | $6.78B | $6.36B | $6.49B | $5.27B | $5.73B |
| Current Liabilities | $1.63B | $1.67B | $1.41B | $1.45B | $1.33B | $1.42B |
| Long-term Debt | $2.38B | $2.18B | $2.56B | $2.67B | - | - |
| Total Liabilities | $4.65B | $4.49B | $4.56B | $4.76B | $4.08B | $4.64B |
| Stockholders' Equity | $2.49B | $2.29B | $1.79B | $1.73B | $1.19B | $1.09B |
| Retained Earnings | $200.30M | ($345.00M) | ($805.60M) | ($858.50M) | ($761.50M) | ($934.10M) |
Cash Flow
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $546.40M | $290.30M | $226.90M | $363.90M | $289.90M | $278.90M |
| Investing Cash Flow | ($161.70M) | $23.60M | ($41.30M) | ($433.10M) | ($99.00M) | ($79.10M) |
| Financing Cash Flow | ($232.70M) | ($424.60M) | ($140.00M) | $295.20M | ($518.30M) | ($108.70M) |
| CapEx | $153.80M | $110.90M | $111.30M | $122.50M | $94.60M | $82.70M |
| Free Cash Flow | $392.60M | $179.40M | $115.60M | $241.40M | $195.30M | $196.20M |
Ratios
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | 21.4% | - |
| Operating margin | 7.3% | 5.1% | 3.4% | 2.0% | 4.8% | - |
| EBITDA margin | 8.8% | 7.2% | 6.1% | 4.3% | 7.0% | - |
| Net margin | 4.8% | 4.8% | 0.6% | -1.1% | 2.1% | - |
| Free cash flow margin | 3.4% | 1.9% | 1.4% | 2.6% | 2.4% | - |
| FCF / Net income | 0.72 | 0.39 | 2.19 | -2.41 | 1.13 | 1.64 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 10.9% | 12.5% | 12.4% | 11.5% | 11.5% | - |
| Effective tax rate | 27.9% | 21.3% | 10.3% | 2430.2% | 22.5% | 29.0% |
| Return on assets | 7.6% | 6.8% | 0.8% | -1.5% | 3.3% | 2.1% |
| Return on equity | 21.9% | 20.1% | 3.0% | -5.8% | 14.5% | 11.0% |
| Return on invested capital | 12.3% | 8.5% | 5.8% | 2.1% | - | - |
| Liquidity | ||||||
| Current ratio | 1.99 | 1.73 | 1.74 | 1.69 | 1.64 | 1.77 |
| Quick ratio | 1.29 | 1.18 | 1.26 | 1.14 | 1.04 | 1.18 |
| Cash ratio | 0.24 | 0.15 | 0.27 | 0.23 | 0.09 | 0.33 |
| Leverage | ||||||
| Debt / Equity | 0.95 | 0.95 | 1.43 | 1.54 | - | - |
| Debt / Assets | 0.33 | 0.32 | 0.40 | 0.41 | - | - |
| Debt / EBITDA | 2.35 | 3.18 | 5.07 | 6.64 | - | - |
| Interest coverage | 7.8x | 4.8x | 2.5x | 1.3x | 2.9x | 2.3x |
| Equity multiplier | 2.86 | 2.96 | 3.55 | 3.75 | 4.42 | 5.26 |
| Liabilities / Assets | 0.65 | 0.66 | 0.72 | 0.73 | 0.77 | 0.81 |
| Efficiency | ||||||
| Asset turnover | 1.61 | 1.41 | 1.30 | 1.43 | 1.53 | - |
| Inventory turnover | - | - | - | - | 7.90 | - |
| Days sales outstanding | 47d | 59d | 55d | 46d | 49d | - |
| Days inventory outstanding | - | - | - | - | 46d | - |
| Days payable outstanding | - | - | - | - | 53d | - |
| Cash conversion cycle | - | - | - | - | 42d | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | 20.3% | 15.4% | -11.0% | 15.0% | - | - |
| Revenue CAGR (3y) | 7.3% | 5.7% | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | -4.3% | 4.5% |
| Operating income growth (YoY) | 72.1% | 71.4% | 50.7% | -51.7% | 9.5% | 309.5% |
| Net income growth (YoY) | 18.4% | 770.7% | - | - | 43.8% | - |
| EPS growth (YoY) | 21.2% | 767.7% | - | - | 42.4% | - |
| EPS CAGR (3y) | - | 30.5% | -28.6% | - | - | - |
| EPS CAGR (5y) | 30.8% | - | - | - | - | - |
| FCF growth (YoY) | 118.8% | 55.2% | -52.1% | 23.6% | -0.5% | -45.4% |
| FCF CAGR (5y) | 14.9% | -13.0% | -4.8% | - | - | - |
| Book value growth (YoY) | 8.8% | 27.9% | 3.4% | 45.4% | 9.3% | 34.6% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2022-12-31.
Product / service
$7.53B totalChemical Distribution$7.25B · 96.2%
Services$286.20M · 3.8%
Geographic
$11.48B totalUS$7.53B · 65.6%
EMEA$2.06B · 18.0%
CA$1.12B · 9.8%
Latin America$756.60M · 6.6%
Stability scores
Altman Z′
FY 2022 · bankruptcy risk
2.37
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2022 · 9-point quality
7/9
Strong
- ✓Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- ✗Long-term debt decreased
- ✓Current ratio improved
- ✓No share dilution
- -Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Wholesale-Chemicals & Allied Products
Comparing Univar Solutions Inc. against the 2 most active filers in the same SIC group.